Advertisement
Home »

Comorbidities Persist for the 90% of Patients With MASH and No Cirrhosis

Sep 30, 2024

REFERENCES & ADDITIONAL READING

Younossi ZM, et al. Hepatol Commun. 2024;8(8):e0488.

ABOUT THE EXPERTS

  • Professor and Chairman of the Department of Medicine
    President of Inova Medicine
    Inova Fairfax Medical Campus
    Inova Health System

MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.


Advertisement
Advertisement
ad
ad
MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.

SUBSCRIBE NOW

View all newsletters

RELEVANT ARTICLES FOR YOU

Advertisement